Quality Systems (QSII) Sends Letter to Shareholders for Value Creation
Tweet Send to a FriendGet Alerts QSII Hot Sheet
Price: $18.41 --0%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 3.9%
Revenue Growth %: +2.1%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 3.9%
Revenue Growth %: +2.1%
Trade QSII Now!
Quality Systems, Inc. (Nasdaq: QSII) announced today it has issued today a letter to all shareholders ahead of the upcoming annual meeting of shareholders on August 16, 2012.
In the letter, QSI provides details on its strategic plan for value creation in the rapidly evolving healthcare IT sector, and information on the recent recommendation by proxy governance firm Egan-Jones to vote for all QSI Board nominees. The company also describes its belief that dissident director Ahmed Hussein’s prohibited trading in QSI shares has contributed to QSI share price decline and argues that Mr. Hussein and his nominees have offered no credible plan for value creation and urges shareholders to vote for QSI’s nominees.
A copy of the letter follows:
NOW IS THE TIME TO PROTECT YOUR INVESTMENTIN QUALITY SYSTEMSVOTE THE ENCLOSED WHITE PROXY CARD TODAY
Dear Fellow Shareholder:
Our annual meeting of shareholders is about two weeks away. We are at a critical point in QSI’s history as we navigate a fast-evolving and ever-changing marketplace. Now more than ever, your vote is crucial in determining the future of our company. We strongly believe we have the right team and the right strategy in place to create value for QSI shareholders. We believe our strategy, already underway, will maximize cross-selling potential and position the company to capitalize on significant and developing industry opportunities. We urge all shareholders to vote the WHITE proxy card today for all QSI’s board nominees at the upcoming annual meeting on August 16, 2012.
Leading Proxy Governance Firm Has Urged Shareholders to Support QSI
Last week Egan-Jones, a leading, independent proxy governance firm, recommended that QSI shareholders vote the white proxy card in favor of QSI’s board nominees, affirming that they are the right leadership team to maximize shareholder returns, now and in the future. We urge you to carefully consider their comments:
“We believe that support for voting the management ballot is merited and that voting the management ballot (WHITE PROXY CARD) is in the best interest of the Company and its shareholders. In arriving at that conclusion, we have considered the following factors:
… the Company’s strategy has positioned it to capitalize on developing trends in the healthcare industry.
… Mr. Hussein’s proxy solicitation is an attempt to take over the Company without paying a premium.
… Mr. Hussein has failed to make a persuasive case that electing his nominees to the board would result in the enhancement of shareholder value.
… not convinced that the election of the dissidents’ slate to the board of directors would work to the benefit of all shareholders.”
We Have the Right Strategy and the Right Board and Management Team toNavigate the Fast-Changing Market Environment
As we discussed on our recent quarterly earnings call, QSI, along with our industry peers, is facing near-term challenges in a rapidly changing market that, at times, can have an impact on our results. A recent research report written by Cowen and Company last week noted the start of a slowdown in the market. However, over the years we have consistently delivered strong shareholder returns -- for example, QSI dividends have increased 40% from $0.50 per share in fiscal 2008 to $0.70 per share in fiscal 2012 -- by successfully navigating difficult environments, and we believe that the strategic steps we have taken during the last few years have positioned QSI to capitalize on future opportunities.
While we are all disappointed in the recent performance of QSI’s stock price, which we believe was negatively impacted by forced sales of QSI stock held in margin accounts of dissident director Ahmed Hussein (prohibited under our insider trading policy - see below), we are confident in our strategy and QSI’s ability to capture significant opportunities for continued revenue and earnings growth over the long term.
We see meaningful opportunity for QSI in a number of areas and are actively positioning the company to seize on this potential. This includes:
Pursuing significant opportunities to sell our electronic health record and complementary solutions. Industry estimates indicate that the addressable market for EHR solutions for physicians and hospitals is only 40% penetrated.
Cross selling new solutions to our existing customer base and bundling multiple solutions for sale to new customers.
Continuing to develop enhancements to our core software products, while developing and acquiring new technologies to capitalize on future growth opportunities and to support new delivery models such as the emerging accountable care organization (ACO) model.
Staying at the forefront of enabling new healthcare delivery models such as ACOs, patient centered medical home and fee for performance models. Many of our new products and enhancements address growing demands on healthcare providers to be more effective in terms of the way they deliver care, manage costs and improve outcomes.
Focusing on growing our RCM services business as the industry seeks to reduce costs by outsourcing billing and collection activities. Management is actively looking to capitalize on the growth and potential we see in the recurring revenue business, in particular, by extending our current RCM capabilities into the dental and hospital markets which we are actively pursuing at this time.
Continuing to focus on acquisitions, of all sizes, that provide a strategic benefit to the company and make financial sense for our shareholders. With 9 acquisitions in the last 4 years, we continually evaluate acquisition opportunities of all sizes. We also will continue to consider larger, more transformative transactions.
Building momentum in our international expansion. Our first international distribution partnership with Dell and Puerto Rico Hospital Supply, Inc., which we announced last June, is an important win for the company and management is keen on furthering this type of growth.
Importantly, as we look ahead to capture growth opportunities, we are working to achieve cost efficiencies that will increase our margins. For example, we have been expanding the use of offshore capabilities for software development and other back office functions.
Vote the WHITE proxy card TODAY for QSI's director nominees —Craig Barbarosh, George Bristol, Mark Davis, Russell Pflueger, Steven Plochocki, Sheldon Razin, Lance Rosenzweig and Maureen Spivack.
Prohibited Trading By Ahmed Hussein Contributed To QSI Share Price Decline
As we explained in the recent special bulletin to shareholders, Mr. Hussein has pledged all of his QSI stock as collateral for margin accounts in flagrant violation of QSI's insider trading policy. We believe that the recent margin calls on Mr. Hussein’s investment accounts, which to date have caused the forced liquidation of at least 1,329,070 shares (representing 2.24 percent of the company’s outstanding common stock), have contributed to the decline in QSI’s share price. We believe that the potential for future margin sales puts the value of your investment in QSI at risk.
Meanwhile, in our opinion, neither Mr. Hussein nor any of his hand-picked nominees has articulated any original strategy for creating value. In fact, Mr. Hussein’s track-record in other businesses and his actions while serving on our Board lead us to believe that any expansion in his influence over the Board would only serve to destroy value in our company’s shares.
The company has established the following website (www.qsi2012proxy.com) containing additional information about our strategy, Mr. Hussein’s history and why we feel that allowing him to nominate a majority of our Board would put your investment at risk. We encourage you to read this important information.
Path To Shareholder Value Is Clear – Vote The White Card Today!
In our view, the path forward is clear. QSI is a company at a critical juncture and is best suited to be guided by our Board nominees and management team with a clear strategic plan to maximize shareholder value. We ask you for your support and urge you to take action today by voting the WHITE proxy card FOR the company’s nominees.
Remember, if you have already voted the gold card IT IS NOT TOO LATE to change your vote as only the most recently voted card counts. Simply vote the WHITE proxy card FOR the company's nominees to protect your investment and the future of QSI.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
In the letter, QSI provides details on its strategic plan for value creation in the rapidly evolving healthcare IT sector, and information on the recent recommendation by proxy governance firm Egan-Jones to vote for all QSI Board nominees. The company also describes its belief that dissident director Ahmed Hussein’s prohibited trading in QSI shares has contributed to QSI share price decline and argues that Mr. Hussein and his nominees have offered no credible plan for value creation and urges shareholders to vote for QSI’s nominees.
A copy of the letter follows:
NOW IS THE TIME TO PROTECT YOUR INVESTMENTIN QUALITY SYSTEMSVOTE THE ENCLOSED WHITE PROXY CARD TODAY
Dear Fellow Shareholder:
Our annual meeting of shareholders is about two weeks away. We are at a critical point in QSI’s history as we navigate a fast-evolving and ever-changing marketplace. Now more than ever, your vote is crucial in determining the future of our company. We strongly believe we have the right team and the right strategy in place to create value for QSI shareholders. We believe our strategy, already underway, will maximize cross-selling potential and position the company to capitalize on significant and developing industry opportunities. We urge all shareholders to vote the WHITE proxy card today for all QSI’s board nominees at the upcoming annual meeting on August 16, 2012.
Leading Proxy Governance Firm Has Urged Shareholders to Support QSI
Last week Egan-Jones, a leading, independent proxy governance firm, recommended that QSI shareholders vote the white proxy card in favor of QSI’s board nominees, affirming that they are the right leadership team to maximize shareholder returns, now and in the future. We urge you to carefully consider their comments:
“We believe that support for voting the management ballot is merited and that voting the management ballot (WHITE PROXY CARD) is in the best interest of the Company and its shareholders. In arriving at that conclusion, we have considered the following factors:
… the Company’s strategy has positioned it to capitalize on developing trends in the healthcare industry.
… Mr. Hussein’s proxy solicitation is an attempt to take over the Company without paying a premium.
… Mr. Hussein has failed to make a persuasive case that electing his nominees to the board would result in the enhancement of shareholder value.
… not convinced that the election of the dissidents’ slate to the board of directors would work to the benefit of all shareholders.”
We Have the Right Strategy and the Right Board and Management Team toNavigate the Fast-Changing Market Environment
As we discussed on our recent quarterly earnings call, QSI, along with our industry peers, is facing near-term challenges in a rapidly changing market that, at times, can have an impact on our results. A recent research report written by Cowen and Company last week noted the start of a slowdown in the market. However, over the years we have consistently delivered strong shareholder returns -- for example, QSI dividends have increased 40% from $0.50 per share in fiscal 2008 to $0.70 per share in fiscal 2012 -- by successfully navigating difficult environments, and we believe that the strategic steps we have taken during the last few years have positioned QSI to capitalize on future opportunities.
While we are all disappointed in the recent performance of QSI’s stock price, which we believe was negatively impacted by forced sales of QSI stock held in margin accounts of dissident director Ahmed Hussein (prohibited under our insider trading policy - see below), we are confident in our strategy and QSI’s ability to capture significant opportunities for continued revenue and earnings growth over the long term.
We see meaningful opportunity for QSI in a number of areas and are actively positioning the company to seize on this potential. This includes:
Pursuing significant opportunities to sell our electronic health record and complementary solutions. Industry estimates indicate that the addressable market for EHR solutions for physicians and hospitals is only 40% penetrated.
Cross selling new solutions to our existing customer base and bundling multiple solutions for sale to new customers.
Continuing to develop enhancements to our core software products, while developing and acquiring new technologies to capitalize on future growth opportunities and to support new delivery models such as the emerging accountable care organization (ACO) model.
Staying at the forefront of enabling new healthcare delivery models such as ACOs, patient centered medical home and fee for performance models. Many of our new products and enhancements address growing demands on healthcare providers to be more effective in terms of the way they deliver care, manage costs and improve outcomes.
Focusing on growing our RCM services business as the industry seeks to reduce costs by outsourcing billing and collection activities. Management is actively looking to capitalize on the growth and potential we see in the recurring revenue business, in particular, by extending our current RCM capabilities into the dental and hospital markets which we are actively pursuing at this time.
Continuing to focus on acquisitions, of all sizes, that provide a strategic benefit to the company and make financial sense for our shareholders. With 9 acquisitions in the last 4 years, we continually evaluate acquisition opportunities of all sizes. We also will continue to consider larger, more transformative transactions.
Building momentum in our international expansion. Our first international distribution partnership with Dell and Puerto Rico Hospital Supply, Inc., which we announced last June, is an important win for the company and management is keen on furthering this type of growth.
Importantly, as we look ahead to capture growth opportunities, we are working to achieve cost efficiencies that will increase our margins. For example, we have been expanding the use of offshore capabilities for software development and other back office functions.
Vote the WHITE proxy card TODAY for QSI's director nominees —Craig Barbarosh, George Bristol, Mark Davis, Russell Pflueger, Steven Plochocki, Sheldon Razin, Lance Rosenzweig and Maureen Spivack.
Prohibited Trading By Ahmed Hussein Contributed To QSI Share Price Decline
As we explained in the recent special bulletin to shareholders, Mr. Hussein has pledged all of his QSI stock as collateral for margin accounts in flagrant violation of QSI's insider trading policy. We believe that the recent margin calls on Mr. Hussein’s investment accounts, which to date have caused the forced liquidation of at least 1,329,070 shares (representing 2.24 percent of the company’s outstanding common stock), have contributed to the decline in QSI’s share price. We believe that the potential for future margin sales puts the value of your investment in QSI at risk.
Meanwhile, in our opinion, neither Mr. Hussein nor any of his hand-picked nominees has articulated any original strategy for creating value. In fact, Mr. Hussein’s track-record in other businesses and his actions while serving on our Board lead us to believe that any expansion in his influence over the Board would only serve to destroy value in our company’s shares.
The company has established the following website (www.qsi2012proxy.com) containing additional information about our strategy, Mr. Hussein’s history and why we feel that allowing him to nominate a majority of our Board would put your investment at risk. We encourage you to read this important information.
Path To Shareholder Value Is Clear – Vote The White Card Today!
In our view, the path forward is clear. QSI is a company at a critical juncture and is best suited to be guided by our Board nominees and management team with a clear strategic plan to maximize shareholder value. We ask you for your support and urge you to take action today by voting the WHITE proxy card FOR the company’s nominees.
Remember, if you have already voted the gold card IT IS NOT TOO LATE to change your vote as only the most recently voted card counts. Simply vote the WHITE proxy card FOR the company's nominees to protect your investment and the future of QSI.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NextGen Healthcare Selected as Healthcare Information Technology Provider for Chinese Hospital
- Vanda (VNDA) Presents Data on Tasimelteon
- Yingli Green Energy (YGE) Updates from Presentation at Intersolar Europe
Create E-mail Alert Related Categories
Corporate News, Management ChangesRelated Entities
Cowen & Co, Dividend, Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
